SEC Form 4 · accession 0000899243-15-007344
Larimar Therapeutics, Inc. · LRMR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert J Perez
Director
Period of report
Oct 28, 2015
Accepted (ET)
Oct 30, 2015 · 5:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001374690
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Oct 28, 2015 | A | 899 | $10.45 | A | 899 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The Common Stock was issued in lieu of cash fees under the Non-Employee Director Compensation Policy pursuant to a Restricted Stock Agreement and the restrictions lapse on December 31, 2015.